These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25120280)

  • 21. The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis.
    Scutigliani EM; Lobo-Cerna F; Mingo Barba S; Scheidegger S; Krawczyk PM
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines.
    Kimura-Tsuchiya R; Ishikawa T; Kokura S; Mizushima K; Adachi S; Okajima M; Matsuyama T; Okayama T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Yagi N; Naito Y; Itoh Y
    J Clin Biochem Nutr; 2014 Jul; 55(1):56-61. PubMed ID: 25120280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
    Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
    Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
    Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
    Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines.
    Okajima M; Kokura S; Ishikawa T; Mizushima K; Tsuchiya R; Matsuyama T; Adachi S; Okayama T; Sakamoto N; Kamada K; Katada K; Uchiyama K; Handa O; Takagi T; Yagi N; Naito Y; Yoshikawa T
    Oncol Rep; 2013 Jun; 29(6):2311-7. PubMed ID: 23589103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.
    Shiota M; Bishop JL; Nip KM; Zardan A; Takeuchi A; Cordonnier T; Beraldi E; Bazov J; Fazli L; Chi K; Gleave M; Zoubeidi A
    Cancer Res; 2013 May; 73(10):3109-19. PubMed ID: 23492367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation.
    Wettstein G; Bellaye PS; Kolb M; Hammann A; Crestani B; Soler P; Marchal-Somme J; Hazoume A; Gauldie J; Gunther A; Micheau O; Gleave M; Camus P; Garrido C; Bonniaud P
    FASEB J; 2013 Apr; 27(4):1549-60. PubMed ID: 23288928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells.
    Yuan GJ; Li QW; Shan SL; Wang WM; Jiang S; Xu XM
    World J Gastroenterol; 2012 Sep; 18(34):4781-6. PubMed ID: 23002349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor.
    Noh H; Kim HJ; Yu MR; Kim WY; Kim J; Ryu JH; Kwon SH; Jeon JS; Han DC; Ziyadeh F
    Lab Invest; 2012 Nov; 92(11):1583-96. PubMed ID: 22964853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.
    Sánchez-Tilló E; Liu Y; de Barrios O; Siles L; Fanlo L; Cuatrecasas M; Darling DS; Dean DC; Castells A; Postigo A
    Cell Mol Life Sci; 2012 Oct; 69(20):3429-56. PubMed ID: 22945800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer.
    Ishikawa T; Kokura S; Sakamoto N; Ando T; Imamoto E; Hattori T; Oyamada H; Yoshinami N; Sakamoto M; Kitagawa K; Okumura Y; Yoshida N; Kamada K; Katada K; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Yagi N; Naito Y; Yoshikawa T
    Int J Hyperthermia; 2012; 28(7):597-604. PubMed ID: 22838644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermia inhibits transforming growth factor beta-induced epithelial-mesenchymal transition (EMT) in HepG2 hepatocellular carcinoma cells.
    Xu XM; Yuan GJ; Li QW; Shan SL; Jiang S
    Hepatogastroenterology; 2012 Oct; 59(119):2059-63. PubMed ID: 22709823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer stem cells: new insights and perspectives.
    Dorado J; Lonardo E; Miranda-Lorenzo I; Heeschen C
    J Gastroenterol; 2011 Aug; 46(8):966-73. PubMed ID: 21698355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
    Conroy T; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Gourgou-Bourgade S; de la Fouchardière C; Bennouna J; Bachet JB; Khemissa-Akouz F; Péré-Vergé D; Delbaldo C; Assenat E; Chauffert B; Michel P; Montoto-Grillot C; Ducreux M; ;
    N Engl J Med; 2011 May; 364(19):1817-25. PubMed ID: 21561347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
    Kim R
    Lancet Oncol; 2011 Jan; 12(1):8-9. PubMed ID: 21050812
    [No Abstract]   [Full Text] [Related]  

  • 39. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
    Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
    Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.